News Archive
digitalMLPA as a Tool for Monitoring Genomic Stability in Stem Cells
MRC Holland and Amsterdam UMC have launched a collaborative project, supported by Health~Holland, and aimed at improving the reliability of patient-derived stem cell models used in personalized medicine. Read more.
Overview of All Our Products Now Available as Custom UCSC Tracks
We've made it easier to explore our product portfolio. You can now view the regions targeted by all our products through custom tracks on the UCSC Genome Browser. Read more.
New Version of Coffalyser digitalMLPA Available
A new version of Coffalyser digitalMLPA – version 2.6 – was recently released. This update further improves the robustness, reliability, and usability of digitalMLPA data analysis. Read more.
Putting CNVs in the Spotlight – Our ESHG 2026 Recap
June marked another outstanding edition of the European Human Genetics Conference, during which we got up to speed with the latest developments in human genetics, and introduced digitalMLPA to an even wider audience. Read more.
Monitor Genomic Integrity of your Stem Cell Cultures with D024 KaryoProfiler
Chromosomal instability and cell line mix-ups are silent but widespread risks in stem cell research, yet routine genomic surveillance remains out of reach for many laboratories. D024 KaryoProfiler is here to fill the gap. Read more.
New Product: NXtec D008 DMD – Gold Standard Certainty for CNV Detection in DMD with Enhanced Resolution
We have just launched NXtec D008 DMD – the first dedicated neuromuscular assay to be added to our digitalMLPA™ catalogue – designed for the reliable detection of CNVs in the DMD gene. Read more.
Updated List of IVDR-Certified Products
We have successfully obtained our certification under the new In Vitro Diagnostic Regulation (IVDR; 2017/746)! The first batch of flagship products are already available on the market under the new IVDR, well in advance of the transition period deadline. Read more.
digitalMLPA as a Valuable Tool in Adult ALL Risk Stratification
D007 Acute Lymphoblastic Leukemia was recognized as a valuable tool for enhanced molecular testing of adult ALL cases in work shown recently at a scientific congress. Read more.
Test Labs Wanted: digitalMLPA NXtec D011 Cardiac Panel
The external test phase for digitalMLPA assay NXtec D011 Cardiac Panel is about to start, and we are looking for test labs. Read more.
Coming Soon: NXtec D008 DMD for Comprehensive CNV Detection in DMD
Our digitalMLPA™ portfolio is about to receive an update with the upcoming launch of NXtec D008 DMD – our first dedicated neuromuscular digitalMLPA assay. Read more.